Sommaire

Numéro précédent

• • ·Editorial board

    Page :A1

    
• • ·Table of contents

    Page :A4

    
• • ·Information for readers

    Page :A21

    
• • ·JAAD Case Reports article list

    Page :A23

    
• • ·Journal based CME instructions and information

    Page :A28

    

• Continuing Medical Education

  • ·The dermatologic oral examination and biopsy: A guide for incorporation into everyday practice

    Page :1399-1410

    Paytra A. Klein, Miguel A. Aristizabal, Marketa Janovska, Alison J. Bruce, Katherine J. Bodiford, Roy S. Rogers

    Résumé Résumé Plan Plan  
  • ·CME examination

    Page :1411

    
  • ·Answers to CME examination

    Page :1412

    
  • ·The dermatologic oral examination: Navigating the Oral Dermatoses Map

    Page :1413-1426

    Paytra A. Klein, Miguel A. Aristizabal, Marketa Janovska, Alison J. Bruce, Katherine J. Bodiford, Roy S. Rogers

    Résumé Résumé Plan Plan  
  • ·CME examination

    Page :1427

    
  • ·Answers to CME examination

    Page :1428

    

• Letter from the Editor

  • ·Letter from the Editor: Standard mean difference versus P value: Why size matters

    Page :1429-1430

    Dirk M. Elston

    

• This Month in JAAD

  • ·This month in JAAD: May 2026

    Page :1431

    Dirk M. Elston

    

• Highlights from JAAD Case Reports

  • ·Highlights from JAAD Case Reports: May 2026

    Page :1432

    Abby Susan Van Voorhees

    

• Highlights from JAAD International

  • ·In vivo skin fluorescence imaging for dysplastic nevi and melanoma

    Page :1433

    Jonathan Kantor

    

• Highlights from JAAD Reviews

  • ·Highlights from JAAD Reviews: May 2026 – Artificial intelligence: Where are we now?

    Page :1434-1435

    Shari R. Lipner

    

• A Clinician's Perspective

  • ·Mitigating dermatologic malpractice risk: Dueling the sword of Damocles

    Page :1436-1437

    Warren R. Heymann

    

• Original Articles

  • ·To test or not to test? Revisiting the value of baseline screening and monitoring tests among biologic treatments for psoriasis using an evidence-based assessment

    Page :1438-1446

    Jessica Q. Duong, Dillon J. Razler, Matthew L. Hrin, William W. Huang, Steven R. Feldman

    Résumé Résumé Plan Plan
  • ·Surgical excision versus topical 5% 5-fluorouracil and photodynamic therapy in the treatment of Bowen's disease: Long-term results of a multicenter randomized controlled trial

    Page :1447-1453

    Myrthe M.G. Moermans, Shima Ahmady, Patty J. Nelemans, Aimée H.M.M. Arits, Janneke P.H.M. Kessels, Han P.A. van Pelt, Nicole W.J. Kelleners-Smeets, Klara Mosterd

    Résumé Résumé Plan Plan  
  • ·Long-term dupilumab efficacy and safety in moderate-to-severe atopic dermatitis: A real-world single-center retrospective study

    Page :1454-1460

    Yun Qiu, Yuan Ding, Wen Hu, Hongjuan Wang, Zixian Lei, Xiaojing Kang

    Résumé Résumé Plan Plan  
  • ·Comparing dermatologists' and artificial intelligence heat maps in dermoscopic image analysis via eye tracking

    Page :1461-1468

    Noa Kremer, Luísa Polo-Silveira, Shirin Bajaj, Samantha Sattler, Allan C. Halpern, Ulas Bagci, Stephen W. Dusza, Kivanc Kose, Jochen Weber, Brian D'Alessandro, Miguel Cordova, Ashfaq A. Marghoob

    Résumé Résumé Plan Plan  
  • ·A new perspective on the treatment and management of atypical nevi: A blinded retrospective analysis of atypical nevi utilizing line-field confocal optical coherence tomography

    Page :1469-1476

    Sherry Ong, Orit Markowitz

    Résumé Résumé Plan Plan  

• From the Academy

  • ·In-office compounding of buffered lidocaine and epinephrine – A stability and safety review

    Page :1477-1482

    Seemal R. Desai, Allison T. Vidimos, Edmund J. Elder, Gigi Davidson, the Compounding Work Group, Murad Alam, Daniel D. Bennett, Brett M. Coldiron, George J. Hruza, Leon H. Kircik, Kelley Pagliai Redbord, Sabra Sullivan, Chad Appel, Lisa Albany

    Résumé Résumé Plan Plan

• Clinical Reviews

  • ·Periorificial dermatitis: Pathophysiology, diagnosis, and management

    Page :1483-1492

    Lorena A. Acevedo-Fontanez, Abizairie Sánchez-Feliciano, Sherry Ershadi, Jason Reichenberg, Lawrence F. Eichenfield, John S. Barbieri

    Résumé Résumé Plan Plan  
  • ·Evaluation and management of mechanical and structural nail disorders: A clinical review

    Page :1493-1503

    Jose W. Ricardo, Judith Dominguez-Cherit, Eckart Haneke, Jasmine Rana, Bertrand Richert, Antonella Tosti, Tracey C. Vlahovic, Shari R. Lipner

    Résumé Résumé Plan Plan  

• Brief Reports

  • ·Differences in prescription patterns among various physician specialties for patients with chronic spontaneous urticaria

    Page :1504-1506

    Peichi Chou, Elaine Ma, Alyssa Roberts, Charlotte Jeong, Abigail Katz, Matthew J. Yan, Nicole Johnsen, Yvonne Nong, Makeila Yee, April Armstrong

     
  • ·Obesity is associated with hair-shaft miniaturization: A cross-sectional analysis

    Page :1506-1508

    Dan Wang, Xiang Gao, Tao Wang, Jian Huang, Pengzhou Li, Liyong Zhu

     
  • ·Cutaneous adverse events associated with mitogen activated protein kinase inhibitors for the treatment of vascular anomalies: A dual-center retrospective study

    Page :1508-1510

    Isabella R. Plumptre, Racquel A. Bitar, Pierre-Olivier Grenier, Yeji Lee, Tishi Shah, Griffin Stockton Hogrogian, Albert C. Yan, Shivangi M. Argade, Melissa A. Casey, Samantha Santos, James R. Treat, Marilyn G. Liang

    
  • ·Biologic therapy and risk of paradoxical eczema in psoriasis: A propensity-matched cohort analysis of tumor necrosis factor-α and interleukin 17 inhibitors using TriNetX

    Page :1510-1513

    Robert Adler, Lori Tsang, Michael Kozlov, Houriah Nukaly, Manan D. Mehta, Emily Cowen, Katerina Svigos, Jessica Lori Feig

    
  • ·Dupilumab treatment improves health-related quality of life in patients with moderate-to-severe atopic dermatitis primarily affecting the hands (atopic hand eczema): Results from a randomized placebo-controlled trial

    Page :1513-1517

    Eric L. Simpson, Marie-Louise A. Schuttelaar, Sonja Molin, Margarida Gonçalo, Jart A.F. Oosterhaven, Xing-Hua Gao, Sumeet Uppal, Dimittri Delevry, Andrew Korotzer, Ana B. Rossi

     
  • ·Out-of-pocket costs of hidradenitis suppurativa are significantly higher than those for psoriasis: A cross-sectional survey study

    Page :1517-1519

    Ellen E. Anshelevich, Lorena A. Acevedo-Fontanez, Natalie M. Baker, Grant J. Riew, Avery H. LaChance, Stephanie R. Cohen, Alexandra P. Charrow

    
  • ·Patient triage for new appointments in medical dermatology may help decrease long waits for urgent and high-risk conditions: A multivariate retrospective analysis of factors associated with appointment lead times

    Page :1519-1521

    Grant J. Riew, David Xiang, Baraa Hijaz, Joseph Michael Yardman-Frank, Gideon P. Smith, Avery H. LaChance, Vinod E. Nambudiri, John Trinidad

     
  • ·Diagnostic utility of serum procalcitonin for early identification of bacterial sepsis in febrile dermatology inpatients: A cohort study of 118 cases

    Page :1521-1523

    Kartik Saini, Naveen Kumar Kansal, Neirita Hazarika, Ajeet Singh Bhadoria, Vishal Gupta, Manisha Naithani, Riti Bhatia

     
  • ·Malpractice litigation in melanoma: Analysis of the LexisNexis Legal Database from 2000 to 2024

    Page :1523-1525

    Isabella Ribaudo, Avery Homer, Laura Xiang, Joshua Arbesman

    
  • ·No association of central centrifugal cicatricial alopecia with type 2 diabetes and hypertension: A retrospective case-control study

    Page :1525-1527

    Michael M. Ong, Wei Li, Kellen Vo Vu, Shari R. Lipner

    
  • ·Minoxidil use and malignancy risk across organ systems: A retrospective cohort study with TriNetX

    Page :1527-1529

    Jack P. Woll, Joshua Bearss, Milan M. Hirpara, Rachel Greene, Natasha A. Mesinkovska

    
  • ·Acitretin and methotrexate in vulvar lichen sclerosus

    Page :1530-1532

    Mariah C. Estill, Maya I. Davis, Kaila G. Moore, Courtney M. Kenyon, Rachel Breidbart, Hannah R. Chang, Melissa M. Mauskar, Alicia J. Little, Margaret M. Cocks, Sarah B. Corley, Erin Foster, Olushola L. Akinshemoyin Vaughn, Vulvar Dermatoses Research Consortium

     
  • ·Cutaneous lupus damage is negatively predicted by disease subtype and systemic involvement and is associated with worse outcomes in body image: A prospective cohort study

    Page :1532-1534

    Tyler B. Cepica, Grace Lu, Lillian Xie, Daniella F. Faden, Caroline J. Stone, Shae Chambers, Rui Feng, Victoria P. Werth, Benjamin F. Chong

    
  • ·Tolerability and safety of concomitant GLP-1 receptor agonist and biologic therapy: A retrospective chart review

    Page :1534-1536

    Juna Khang, Rebeca Martinez, Katherine Brag, Jean S. McGee

    
  • ·Real-world experience of JAK inhibitors in eyebrow regrowth for alopecia areata: A retrospective single-center study

    Page :1536-1539

    Ruxin Ji, Jundong Huang, Jia Jian, Jiri Cao, Min Li, Tian Tian, Xiaobing Liang, Ji Li, Fangfen Liu, Wei Shi

     
  • ·Ochre fluorescence under ultraviolet-induced fluorescence dermatoscopy is a strong clue to melanoma: Results of an international retrospective cross-sectional study

    Page :1539-1541

    Paweł Pietkiewicz, Marian Voloshynovych, Julien Anriot, Marta Koper, Natalia Salwowska, Katarzyna Kowalska, Agnieszka Malińska, Magdalena Ciążyńska, Tetiana Boichuk, Pablo Vargas-Mora, Agnieszka Leszczyńska-Pietkiewicz, Sanjana Sara Sunil, Cristian Navarrete-Dechent

     
  • ·In vitro assessment of a combination therapy of abametapir and flavesone as a novel topical single-dose scabies treatment

    Page :1541-1543

    Deepani D. Fernando, Gangi R. Samarawickrama, Nirupama A. Nammunige, Gunter Hartel, Vern Bowles, Katja Fischer

     
  • ·Diverse clinical course and features of verrucous venous malformation

    Page :1543-1545

    Shih-Jen Chang, Jingjing Sun, Qianyi Chen, Lizhen Wang, Xiaoxi Lin, Yajing Qiu

     
  • ·Hormonal contraception and development of periorificial dermatitis: A retrospective cohort study using the TriNetX database

    Page :1545-1547

    Christopher J. Thang, Jenny Lai, David Garate, Abizairie Sánchez-Feliciano, George Golovko, Michael G. Wilkerson, John S. Barbieri

    
  • ·Distinguishing acute skin failure in the critically ill: A retrospective cohort study

    Page :1547-1549

    Peyton V. Warp, Robert S. Kirsner, Scott A. Elman

    Plan Plan
  • ·How small is too small to see: Defining the visual detection threshold for basal cell carcinomas

    Page :1549-1551

    Luísa Polo-Silveira, Stephen W. Dusza, Ashfaq Marghoob

     
  • ·Apremilast drug survival and tolerability in real-world practice

    Page :1551-1553

    Stavritsa Taxiarchoula Varvara, Nikolaos Chaitidis, Maria Daviti, Aikaterini Tsentemeidou, Michail Panagiotidis, Elena Sotiriou, Vlassios Eleftheriadis, Grigorios T. Sakellariou, Eleni Paschou, Vasiliki Pelitari, Eleonora Gatsiou, Aggeliki Geroutziafa, Asterios Papadopoulos

     
  • ·Evaluation of carbon-dioxide laser grinding as a treatment for ingrown toenail

    Page :1553-1555

    Sun Gyu Kim, Woo Jin Ahn, Hyun-Min Seo, Joung Soo Kim

     
  • ·Ocular and auditory associations in patients with vitiligo: A single-center retrospective study of 8512 patients

    Page :1555-1557

    Frank Z. Jing, Tyler A. Bahr, Austin Todd, Raymond Iezzi, Afsaneh Alavi

    
  • ·Underutilization of patch testing for contact dermatitis: Insights from DataDerm

    Page :1557-1559

    Alexander Idrogo-Lam, Arik Aninos, Margo Reeder

     
  • ·Racial disparities in dermatofibrosarcoma protuberans: A retrospective cohort study

    Page :1559-1560

    Maggie H. Zhou, Wei Li, Alexis Mitelman, Anisah Alladeen, Chelsea Handfield, Kira Minkis, Igor Matushansky, Shari R. Lipner

    
  • ·Pentoxifylline and long-term risk of keloid formation: A real-world 10-year outcomes study using TriNetX

    Page :1561-1563

    Robert Adler, Michael Kozlov, Fariha Ahmed, Kathryn Liston, Manan D. Mehta, Emily Cowen, Katerina Svigos, Eve J. Lowenstein

    
  • ·Complete tissue sectioning: Combined processing technique for dermatologic studies requiring confirmation of disease clearance

    Page :1563-1565

    Marie Clark, Jalal Maghfour, Ben J. Friedman, Jennifer Healy, Molly Powers, David Ozog

    Plan Plan  
  • ·Recognizing the shift toward prepectoral breast implants: Implications for dermatologic surgery

    Page :1565-1567

    Megan Trager, Emily Gale, Karen Connolly, Joseph Disa, Kishwer Nehal

     

• Health Policy & Practice

  • ·Impact of state-level indoor tanning legislation on adolescent behavior and ultraviolet radiation exposure in the United States: A policy-based narrative review

    Page :1568-1569

    Areeba Ahmed, Meredith Hengy, Geoffrey Potts

    

• Dermatology Images

  • ·Mycosis fungoides

    Page :1570-1583

    Yin Yu, Silvija Gottesman, Hongyu Yang, Sheng Zhong, Qiao Liu, Lin Feng

     

• Humanities

  • ·Artificial intelligence-generated music promoting medical education

    Page :1584-1585

    Bryce DeLong, Melissa Piliang, Robert T. Brodell, Matthew Molenda

    

• Medical Error & Patient Safety

  • ·A forty-year review of Canadian medico-legal cases involving skin cancer

    Page :1586-1588

    Ammar Saed Aldien, Eric McMullen, Rahul Nanda, Ghassan Barnawi, Cen Feng Yang, Ivan V. Litvinov, Elena Netchiporouk

    Plan Plan  
  • ·Cryotherapy medicolegal liability claims amongst physicians in North America (1988-2025)

    Page :1589-1592

    Raquel Lazarowitz, Ghassan Barnawi, Mark Lazarowitz, Vincent Piguet

    

• Ethics Journal Club

  • ·Protecting learner autonomy in dermatology: Ethics involved in non-indicated volunteer peer procedures

    Page :1593-1594

    Janice Kim, Tarek Zieneldien, Sophia Ma, Jane M. Grant-Kels

    
  • ·Ethical considerations in interpreting nonverbal communication in dermatology

    Page :1595-1596

    Isabella J. Tan, Tarek Zieneldien, Sophia Ma, Jane M. Grant-Kels

    
  • ·Navigating patient portal overuse: Ethical strategies for compassionate care

    Page :1597-1598

    Gabrielle Schwartzman, Aaron D. Smith, Pradip Ramamurti, R. Hal Flowers, Jane M. Grant-Kels

    
  • ·Rare tumors, rare dilemmas: Ethical considerations for a clinician-researcher

    Page :1599-1600

    Minh B. Nguyen, Tejas P. Joshi

    
  • ·Ethical issues of private practice experiences during dermatology residency training

    Page :1601-1602

    Timothy Klufas, Samantha Strelzer, Albert E. Zhou, Jane M. Grant-Kels

    
  • ·Preserving youth or protecting patients? Ethical reflections on beneficence and autonomy

    Page :1603-1604

    Rita El Jbeily, Jane M. Grant-Kels

    
  • ·Ethical considerations in balancing dermatologic symptom control and systemic risks of polypharmacy in geriatrics

    Page :1605-1606

    Janice Kim, Tarek Zieneldien, Sophia Ma, Isabella J. Tan, Jane M. Grant-Kels

    
  • ·Where culture meets cosmetic dermatology: Ethical approaches to body dysmorphic disorder concern

    Page :1607-1608

    Tarek Zieneldien, Sophia Ma, Ali Aljassabi, Jane M. Grant-Kels

    
  • ·Navigating patient care challenges in the aftermath of a domestic natural disaster

    Page :1609-1611

    Eunheh Koh, Alexandra W. Hickman, Jane M. Grant-Kels

     
  • ·Dermatologists serving as medical spa directors without providing oversight

    Page :1612-1613

    Aaron D. Smith, Gabrielle Schwartzman, Catherine E. Lyons, Markus D. Boos, Jane M. Grant-Kels

    

• Corrections

  • ·Correction

    Page :1614

    
  • ·Correction

    Page :1614-1616

     
  • ·Correction

    Page :1616-1617

    
  • ·Correction

    Page :1617

    
  • ·Correction

    Page :1617-1618

    

• JAAD Online

  • ·Ethical challenges in iPLEDGE: Barriers to access and autonomy

    Page :e333

    Malak Husseinali, Tejas P. Joshi, Rishabh Lohray, Erica Ogwumike, Rajani Katta, Dina Zamil

    
  • ·Navigating ethical challenges in psychodermatology care where mental health is stigmatized

    Page :e335

    Tarek Zieneldien, Sophia Ma, Jane M. Grant-Kels, Mohammad Jafferany

    
  • ·The price of entry: Debt reform and its effects on medical education and the field of dermatology

    Page :e337

    Ayushya Ajmani, Albert E. Zhou, Madeleine Tessier-Kay, Jane M. Grant-Kels, Daniel M. Klufas

    
  • ·Use of artificial intelligence for dermatologic diagnosis: Ethical issues with integration of new technologies

    Page :e339

    Isabella J. Tan, Tarek Zieneldien, Sophia Ma, Jane M. Grant-Kels

    
  • ·Dermatologists' ethical role in product sustainability

    Page :e341

    Isabella J. Tan, Tarek Zieneldien, Sophia Ma, Jane M. Grant-Kels

    Plan Plan
  • ·Clinical and ethical limits in occupational dermatology

    Page :e343

    Isabella J. Tan, Tarek Zieneldien, Sophia Ma, Jane M. Grant-Kels

    
  • ·Ethical considerations of scheduling patients in dermatology resident clinics

    Page :e345

    Aarushi K. Parikh, Dustine Reich, Alexa S. Podolsky, Shari R. Lipner

    Plan Plan
  • ·Ethical considerations for managing skin cancer in patients with advanced dementia

    Page :e347

    Umayr R. Shaikh, Leela K. Raj, Christopher G. Richter, Daniel M. Klufas, Jane M. Grant-Kels

    
  • ·Ethical implications of who discloses dermatopathology results to patients

    Page :e349

    Julia Ross, Timothy Klufas, Albert E. Zhou, Jane M. Grant-Kels

    Plan Plan
  • ·Behind the label: Dermatologists' endorsements and consumer perceptions

    Page :e351

    Madeleine Tessier-Kay, Albert E. Zhou, Jane M. Grant-Kels

    
  • ·Clinical pearl: Topical Lactobacillus application to disrupt Pseudomonas aeruginosa biofilms and promote healing in chronic wounds

    Page :e353

    Tassilo Dege, Andreas Kerstan, Matthias Goebeler, Astrid Schmieder

     
  • ·Novel technique to support the diagnosis of intraungual and/or subungual hemorrhage

    Page :e357

    Deepti Singh, Arun Philips, Siddhartha Siddeswara, Avanija Sai Gajula, Sheetanshu Kumar, Rashmi Kumari

    Plan Plan  
  • ·A modified self-made negative pressure drainage device for skin wound management

    Page :e359

    Chao Lian, Yuren Duan, Fei Fan, Xuanfen Zhang

     
  • ·Response to Lian et al, “A modified self-made negative pressure drainage device for skin wound management”

    Page :e361

    Qiuyun Xu, Songyu Wang, Shuyi Shen, Ting Gong, Fang Fang, Chao Ji

    Plan Plan
  • ·Methodological considerations of GPT-4 Vision in dermoscopic image analysis: comment on “Comparative assessment of GPT-4 Vision in dermoscopic image analysis”

    Page :e363

    Jianhao Ke, Hongfeng Mao, Hui Deng

    
  • ·Response to Ke et al., “Methodological considerations of GPT-4 vision in dermoscopic image analysis”

    Page :e365

    Andrew R. Tadros, Weipeng Zhuo, Ramie A. Fathy, Michelle A. Robinson, Micah Belzberg, Jihad M. Alhariri

    
  • ·Response to Kim et al “Legislative efforts to expand insurance coverage of wigs for individuals with medical causes of alopecia”

    Page :e367

    Sabrina Sadeghian, Radhika Gupta, Jerry Shapiro, Mario Lacouture, Ian W. Tattersall, Kristen I. Lo Sicco

    
  • ·Response to Zhang et al, “Response to Srivatsa et al, ‘The role of upadacitinib in refractory dermatomyositis: A systematic review’”

    Page :e369

    Anagha Srivatsa, Marissa Yaldo, Rafey Rehman, Meena Moossavi, Geoffrey Potts, Darius Mehregan

    
  • ·Response to Srivatsa et al, “The role of upadacitinib in refractory dermatomyositis: A systematic review”

    Page :e371

    Hanlin Zhang, Keyun Tang, Jindi Feng, Hongzhong Jin

    
  • ·Rebuilding the rural dermatology workforce: Sustainable solutions for America's dermatology deserts

    Page :e373

    Danielle M. Khalilzadeh, Seda Sahin, Natasha L. Salmen, Albert E. Zhou, Hao Feng, Jane M. Grant-Kels

    
  • ·Commentary on “Evaluating the performance of ChatGPT on dermatology board-style exams: A meta-analysis of text-based and image-based question accuracy” by Chen et al

    Page :e375

    Fei Sun, Li Yuan, Xia Lei, Shuixian Zhang, Lin Zhou

    
  • ·RE: “Plumage sign” helps clinicians easily identify pigmented squamous cell carcinoma in situ

    Page :e377

    Michael Christopher, Cristian Navarrete-Dechent

     
  • ·Comment on ‘Efficacy, safety, and B-cell depletion capacity of 3 rituximab dosing regimens in the treatment of moderate-to-severe pemphigus vulgaris and pemphigus foliaceus: A 52-week clinical trial’

    Page :e379

    Cheng Xue

    Plan Plan
  • ·Response to Xue et al, “Comment on ‘Efficacy, safety, and B-cell depletion capacity of 3 rituximab dosing regimens in the treatment of moderate-to-severe pemphigus vulgaris and pemphigus foliaceus: A 52-week clinical trial’”

    Page :e381

    Tingting Liu, Shan Cao, Xitong Zhao, Zhenzhen Wang, Hong Liu, Furen Zhang

     
  • ·Disparities in Mohs utilization and margin outcomes in sebaceous carcinoma: A response to Zhou et al.

    Page :e383

    Bryan Nolasco, Rafi Kabarriti, Emily R. Nadelmann

    
  • ·The passing of Alfred W. Kopf, MD

    Page :e387

    Darrell S. Rigel

     
  • ·Review of Practical Facial Reconstruction: Theory and Practice

    Page :e389

    Siddharth Srikakolapu

    
  • ·May 2026 IOTADERMA (#387)

    Page :e391

    Robert I. Rudolph